Cross Country Healthcare Stock Forecast for 2023 - 2025 - 2030

Updated on 05/12/2024

Stock Rating
13
Price Target
$18.50
Consensus
Neutral
Upside
23.91%
Analysts
6
Stock Rating
13
Upside
23.91%
Analysts
6
Price Target
$18.50

Cross Country Healthcare Stock Forecast and Price Target

Cross Country Healthcare's stock is projected to advance by 23.91% from the previous closing price if it reaches the average target of $18.50 by the year's end, as six reputable analysts recently projected. This potential upside is calculated on a high-end estimate of $21.00 and a low-end estimate of $16.00. If you are not interested in CCRN stock, you may be interested in its competitors.

$18.50

23.91% Upside

Hold
Hold

Cross Country Healthcare Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Cross Country Healthcare's Price has fallen from $11.76 to $0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of $40.13, which would mean an increase of 100.00%. Over the next seven years, experts predict that Cross Country Healthcare's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$40.13
2025 Fair Value Forecast
$45.50
2026 Fair Value Forecast
$43.71
2027 Fair Value Forecast
$28.02
2028 Fair Value Forecast
$32.53
2029 Fair Value Forecast
$37.54
2030 Fair Value Forecast
$41.14
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
RHI Stock Forecast Robert Half Hold 10
$70.76 Buy/Sell $72.50 -1.07%
TEP Stock Forecast Teleperformance Outperform 18
102.60€ Buy/Sell 193.07€ 46.20%
CBZ Stock Forecast CBIZ Outperform 16
$77.00 Buy/Sell $60.00 1.30%
MAN Stock Forecast ManpowerGroup Hold 18
$76.70 Buy/Sell $74.83 1.69%
KFY Stock Forecast Korn Ferry Outperform 18
$64.52 Buy/Sell $81.50 13.14%

Cross Country Healthcare Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Cross Country Healthcare's Revenue has grown by 141.47%, rising from $836.42M to $2.02B. According to 7 analysts, Cross Country Healthcare's Revenue will fall by 19.21% in the next year, reaching $1.63B. Professionals believe that By 2030, Cross Country Healthcare's Revenue will fall to $1.87B – a 7.62% decrease from its current value.

2024 Rev Forecast
$1.63B
2025 Rev Forecast
$1.64B
2026 Rev Forecast
$1.98B
2027 Rev Forecast
$2.02B
2028 Rev Forecast
$1.89B
2029 Rev Forecast
$1.81B
2030 Rev Forecast
$1.87B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
KELY.A Stock Forecast Kelly Services Outperform 17
$23.21 Buy/Sell $26.67 24.95%
BBSI Stock Forecast Barrett Business Services Outperform 16
$125.98 Buy/Sell $130.75 11.53%
HSII Stock Forecast Heidrick & Struggles Internati... Outperform 17
$33.22 Buy/Sell $36.00 20.41%

Cross Country Healthcare Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
HCKT Stock Forecast The Hackett Group Outperform 18
$21.89 Buy/Sell $27.00 21.06%
RGP Stock Forecast Resources Connection Hold 18
$11.30 Buy/Sell $16.00 15.04%
TBI Stock Forecast TrueBlue Outperform 13
$10.82 Buy/Sell $17.67 20.15%

Cross Country Healthcare Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$0.10B
2025 FCF Forecast
$0.09B
2026 FCF Forecast
$0.10B
2027 FCF Forecast
$0.10B
2028 FCF Forecast
$0.10B
2029 FCF Forecast
$0.09B
2030 FCF Forecast
$0.10B

Cross Country Healthcare EBITDA Forecast for 2023 - 2025 - 2030

Cross Country Healthcare's EBITDA has seen impressive growth In the last three years, rising from $25.89M to $134.96M – a growth of 421.28%. For the following year, the 7 analysts predict that Cross Country Healthcare's EBITDA will drop by 20.28%, reaching $107.59M. In 2030, the professionals' prediction is that CCRN's EBITDA will decrease by 15.67%, reaching $113.81M.

2024 EBITDA Forecast
$0.11B
2025 EBITDA Forecast
$0.12B
2026 EBITDA Forecast
$0.11B
2027 EBITDA Forecast
$0.12B
2028 EBITDA Forecast
$0.12B
2029 EBITDA Forecast
$0.12B
2030 EBITDA Forecast
$0.11B

Cross Country Healthcare EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Cross Country Healthcare's EBIT has grown by 617.59%, rising from $16.32M to $117.11M. In the following year, the 4 analysts surveyed believe that Cross Country Healthcare's EBIT will decrease by 30.25%, reaching $81.68M. According to professionals, by 2030, Cross Country Healthcare's EBIT will have decreased by 21.53%, falling down to $91.90M.

2024 EBIT Forecast
$0.08B
2025 EBIT Forecast
$0.08B
2026 EBIT Forecast
$0.09B
2027 EBIT Forecast
$0.10B
2028 EBIT Forecast
$0.10B
2029 EBIT Forecast
$0.09B
2030 EBIT Forecast
$0.09B

Cross Country Healthcare EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Cross Country Healthcare's EPS has fallen from $0.46 to $0.00 – a 100.00% decrease. For next year, analysts predict EPS of $1.57, which would mean an increase of 100.00%. Over the next seven years, experts predict that Cross Country Healthcare's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$1.57
2025 EPS Forecast
$1.78
2026 EPS Forecast
$1.71
2027 EPS Forecast
$1.10
2028 EPS Forecast
$1.27
2029 EPS Forecast
$1.47
2030 EPS Forecast
$1.61